The development of anemia in patients with decreased renal function is thought to be related to other comorbidities such as diabetes, where the EPO deficiency is a consequence of interstitial fibrosis, diabetic nephropathy, or glycation of the EPO receptor due to hyperglycemic status [15]. The gene discussed is EPO; the disease is anemia.